» Articles » PMID: 39723228

Towards Risk Stratification in Clinical Care for IgA Nephropathy: Genetic Risk Scores: Comments on the Study "Clinical Application of Polygenic Risk Score in IgA Nephropathy"

Overview
Journal Phenomics
Publisher Springer
Date 2024 Dec 26
PMID 39723228
Authors
Affiliations
Soon will be listed here.
References
1.
Sinnott-Armstrong N, Tanigawa Y, Amar D, Mars N, Benner C, Aguirre M . Genetics of 35 blood and urine biomarkers in the UK Biobank. Nat Genet. 2021; 53(2):185-194. PMC: 7867639. DOI: 10.1038/s41588-020-00757-z. View

2.
Kiryluk K, Li Y, Scolari F, Sanna-Cherchi S, Choi M, Verbitsky M . Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens. Nat Genet. 2014; 46(11):1187-96. PMC: 4213311. DOI: 10.1038/ng.3118. View

3.
Barbour S, Canney M, Coppo R, Zhang H, Liu Z, Suzuki Y . Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool. Kidney Int. 2020; 98(4):1009-1019. DOI: 10.1016/j.kint.2020.04.042. View

4.
Holscher D, Bouteldja N, Joodaki M, Russo M, Lan Y, Vafaei Sadr A . Next-Generation Morphometry for pathomics-data mining in histopathology. Nat Commun. 2023; 14(1):470. PMC: 9884209. DOI: 10.1038/s41467-023-36173-0. View

5.
Feehally J, Farrall M, Boland A, Gale D, Gut I, Heath S . HLA has strongest association with IgA nephropathy in genome-wide analysis. J Am Soc Nephrol. 2010; 21(10):1791-7. PMC: 3013538. DOI: 10.1681/ASN.2010010076. View